Iolascon A, Lo Cunsolo C, Giordani L, Cusano R, Mazzocco K, Boumgartner M, Ghisellini P, Faienza M F, Boni L, De Bernardi B, Conte M, Romeo G, Tonini G P
Department of Biomedicine of Evolutive Age, University of Bari, Genova, Italy.
Cancer Lett. 1998 Aug 14;130(1-2):83-92. doi: 10.1016/s0304-3835(98)00122-0.
We studied chromosome 1p loss of heterozygosity (1p-LOH) in 53 neuroblastomas (NBs) using 15 (CA)n repeat loci, which covered a region of 90 cM. We also assessed chromosome 1p36 deletion by fluorescence in situ hybridization (FISH) on interphase nuclei. 1p-LOH was found in 19 (36%, 95% confidence interval (CI) 23-50%) NBs. We detected interstitial and large deletion in both localized and disseminated tumours and in one tumour of a patient at stage 4S. Allelic loss was frequently observed in 1p36 and 1p32 regions. In patients older than 1 year of age (53 versus 13%, P < 0.002) we detected significant chromosome 1p deletion and it was associated with MYCN amplification (P = 0.001). Overall survival (OS) analysis showed that 1p-LOH is predictive of a poor outcome (odds ratio 16.5, 95% CI 5.4-50.9%); therefore, 1p-LOH should be regarded as an additional tumour progression marker in neuroblastoma.
我们使用15个(CA)n重复位点对53例神经母细胞瘤(NBs)进行了1号染色体杂合性缺失(1p-LOH)研究,这些位点覆盖了90 cM的区域。我们还通过间期核荧光原位杂交(FISH)评估了1号染色体1p36缺失情况。在19例(36%,95%置信区间(CI)23 - 50%)NBs中发现了1p-LOH。我们在局限性和播散性肿瘤以及1例4S期患者的肿瘤中均检测到了间质和大片段缺失。在1p36和1p32区域经常观察到等位基因缺失。在1岁以上的患者中(53%对13%,P < 0.002),我们检测到显著的1号染色体1p缺失,且其与MYCN扩增相关(P = 0.001)。总生存(OS)分析表明,1p-LOH预示预后不良(优势比16.5,95% CI 5.4 - 50.9%);因此,1p-LOH应被视为神经母细胞瘤中一个额外的肿瘤进展标志物。